This multi-institutional study analyzed 10,607 patients who underwent surgical aortic valve replacement between 2002 and 2023 to assess the prevalence, predictors, and outcomes of prosthesis-patient mismatch (PPM).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic Surgery
July 3, 2025
This study evaluated the long-term effects of blood pressure (BP) and heart rate (HR) on 839 patients post-surgical repair of acute type A aortic dissection. Key findings showed that a systolic BP over 150 mm HG at discharge correlated with increased mortality.
June 18, 2025
There is an established difference in presentation, pattern of disease progression, and long-term outcomes in males and females presenting with cardiovascular disease. It is also known that aortic insufficiency (AI) severity and left ventricular dilatation are closely associated in males, but not in females.
May 29, 2025
This article studied the use of both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) in patients with low-flow, low-gradient aortic stenosis, including both classical and paradoxical variants of the condition.
May 15, 2025
Transcatheter aortic valve implantation (TAVI) has emerged as the treatment of choice for symptomatic severe aortic stenosis (AS) across the whole surgical risk spectrum.
May 1, 2025
Women with severe symptomatic aortic stenosis are underrepresented in clinical trials. The Randomized Research in Women All Comers with Aortic Stenosis (RHEIA) trial investigates the balance of benefits and risks of transcatheter aortic valve implantation (TAVI) compared to surgery in women.
April 24, 2025
The Evolut Low Risk trial demonstrated that transcatheter aortic valve replacement (TAVR) was noninferior to surgery for the primary endpoint of all-cause mortality or disabling stroke at two years. In this new publication, the authors report the five-year outcomes of the Evolut Low Risk trial.
April 3, 2025
In a large cohort of 632 patients who underwent “true redo root" surgery (reoperative aortic root surgery after a previous aortic root procedure), the indications for endocarditis and the presence of a previous prosthetic aortic root graft increased the complexity of the procedure and the perioperative course; however, it did not impact the operative
Low-Dose Warfarin With a Novel Mechanical Aortic Valve: Interim Registry Results at 5-Year Follow-Up
April 3, 2025
This study evaluated the safety of low-dose warfarin (target INR 1.8) combined with daily aspirin (75 100 mg) after On-X mechanical aortic valve implantation.
January 30, 2025
This study evaluated long-term outcomes of bioprosthetic and mechanical aortic valve replacement (AVR) using data from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD).